| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $21.24 ▲ +1.68% | wingi | $20.74 ▼ -0.71% | Sesuk Monte Rosa Therapeutics Inc. Common Stock (GLUE) persiyapan wis anchored kanggo $20.89 lan target $21.24 (+1.68%). Waca sing cedhak yaiku munggah; nonton $21.52 / $20.26 amarga volatilitas sing diwujudake saben dina babagan 8.00%. |
Sesuk Monte Rosa Therapeutics Inc. Common Stock (GLUE) persiyapan wis anchored kanggo $20.89 lan target $21.24 (+1.68%). Waca sing cedhak yaiku munggah; nonton $21.52 / $20.26 amarga volatilitas sing diwujudake saben dina babagan 8.00%. | ||||
| Minggu | $21.98 ▲ +5.23% | Minggu kepungkur | $20.43 ▼ -2.19% | Model 7 dina Monte Rosa Therapeutics Inc. Common Stock pindhah saka $20.43 menyang $21.98 (+5.23%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $21.52 / $20.26 prakara luwih saka siji obah. |
Model 7 dina Monte Rosa Therapeutics Inc. Common Stock pindhah saka $20.43 menyang $21.98 (+5.23%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $21.52 / $20.26 prakara luwih saka siji obah. | ||||
| wulan | $23.21 ▲ +11.13% | Wulan kepungkur | $19.91 ▼ -4.67% | Target 1 wulan Monte Rosa Therapeutics Inc. Common Stock yaiku $23.21 (+11.13%), dibandhingake karo referensi langsung ing cedhak $20.89. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Monte Rosa Therapeutics Inc. Common Stock yaiku $23.21 (+11.13%), dibandhingake karo referensi langsung ing cedhak $20.89. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $25.06 ▲ +19.98% | Taun kepungkur | $19.14 ▼ -8.39% | Skenario 1 taun Monte Rosa Therapeutics Inc. Common Stock nuduhake $25.06 (+19.98%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Monte Rosa Therapeutics Inc. Common Stock nuduhake $25.06 (+19.98%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $29.40 ▲ +40.71% | 5 Taun kepungkur | $17.32 ▼ -17.10% | Tampilan 5 taun Monte Rosa Therapeutics Inc. Common Stock yaiku $29.40 (+40.71%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Monte Rosa Therapeutics Inc. Common Stock yaiku $29.40 (+40.71%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $20.89 | agêng |
| Ganti saben dina | +5.45% | Ndhuwur |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 69% | Ndhuwur |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $20.89 | Ganti saben dina | +5.45% |
| Pasar Kab | $1.67B | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.